A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin Lispro-aabc; Drug: Insulin Glargine Sponsors: Eli Lilly and Company; Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Conditions: Diabetes, Type 2 Interventions: Drug: Insulin icodec; Drug: Insulin glargine Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
Conditions: Type 2 Diabetes Interventions: Drug: IcoSema; Drug: Insulin glargine Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia
Conditions: Glycemic Control; Insulin; Critical Illness Interventions: Drug: Insulin Glargine; Drug: Insulin Degludec; Drug: Insulin regular Sponsors: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes
Conditions: Insulin Pump ，Continuous Glucose Monitoring Technology Interventions: Drug: Insulin Glargine; Drug: Metformin; Drug: Dapagliflozin; Drug: Insulin aspart Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Conditions: Type 2 Diabetes Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
Conditions: Type2diabetes Interventions: Drug: Insulin Glargine 100 UNT/ML Pen Injector [Lantus]; Drug: Saxagliptin 2.5 mg/ Metformin Hydrochloride extended release 1000 mg; Drug: Pioglitazone 30mg Sponsors: University of Basrah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
